Product NDC: | 13537-153 |
Proprietary Name: | ESIKA |
Non Proprietary Name: | Avobenzone, Octisalate, Octocrylene, and Oxybenzone |
Active Ingredient(s): | .03; .05; .1; .06 g/mL; g/mL; g/mL; g/mL & nbsp; Avobenzone, Octisalate, Octocrylene, and Oxybenzone |
Administration Route(s): | TOPICAL |
Dosage Form(s): | LIQUID |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 13537-153 |
Labeler Name: | Ventura Corporation, Ltd. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part352 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20120124 |
Package NDC: | 13537-153-01 |
Package Description: | 150 mL in 1 BOTTLE, PLASTIC (13537-153-01) |
NDC Code | 13537-153-01 |
Proprietary Name | ESIKA |
Package Description | 150 mL in 1 BOTTLE, PLASTIC (13537-153-01) |
Product NDC | 13537-153 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Avobenzone, Octisalate, Octocrylene, and Oxybenzone |
Dosage Form Name | LIQUID |
Route Name | TOPICAL |
Start Marketing Date | 20120124 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Ventura Corporation, Ltd. |
Substance Name | AVOBENZONE; OCTISALATE; OCTOCRYLENE; OXYBENZONE |
Strength Number | .03; .05; .1; .06 |
Strength Unit | g/mL; g/mL; g/mL; g/mL |
Pharmaceutical Classes |